JPRN-jRCTs051180037已完成2 期
Clinical utility of PET/CT with 18F-FSU-880 for recurrent prostate cancer - PSMA PET for recurrent prostate cancer
akamoto Yuji0 个研究点目标入组 74 人开始时间: 2019年1月29日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 74
研究概览
简要总结
PET/CT using 18F-FSU-880 would be useful in patients with suspected recurrence after primary treatment of prostate cancer.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 85age old（—）
- 性别
- Male
入选标准
- •1. Patients (Age 20-85 y.o.) with prostate cancer
- •2. Patients who are suspected of having recurrence due to their increased PSA or diagnostic imaging after surgery for prostate cancer
- •3. Patients who are determined to be appropriate for this study by participating physicians according to the results of physical examination and blood/urine/physiological function tests.
- •4. Patients who give us written informed consent
排除标准
- •1. Patients having a severe communication problem.
- •2. Patients with severe general condition.
- •3. Patients having severe renal dysfunction (eGFR<30 mL/min/1.73m3) expected to affect the distribution of [18F]FSU-880..
- •4. Patients to whom participating physicians judged to be inappropriate for this study.
研究者
相似试验
已完成
2 期
Clinical utility of PET/CT with 18F-FSU-880 for recurrent prostate cancerprostate cancerJPRN-UMIN000034190Kyoto University Hospital74
招募中
不适用
18F-FAPI PET/CT in Patients With Various Types of CancerCancerNCT05810324Jilin University500
Unknown
不适用
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer PatientsEndometrial CancerNCT05056259Assiut University42
招募中
早期 1 期
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid TumorTumor, SolidNCT06126705Affiliated Hospital of North Sichuan Medical College60
招募中
不适用
18F-FDHT PET/CT for re-staging patients with recurrent of prostate cancer after radiotherapy; a pilot studyprostate cancerNL-OMON43219niversitair Medisch Centrum Groningen20